Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cardiovascular Disorders

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Hypertension in Cameroon associated with high likelihood of obstructive sleep apnea: a pilot study

  • Alfred Kongnyu Njamnshi1,
  • Michel Karngong Mengnjo1,
  • Eta Ngole Mbong1, 2Email author,
  • Samuel Kingue1,
  • Julius Yundze Fonsah1,
  • Andreas Ateke Njoh1,
  • Leonard Njamnshi Nfor1,
  • Leonard Ngarka1,
  • Samuel Eric Chokote1 and
  • Felicien Enyime Ntone1
Contributed equally
BMC Cardiovascular DisordersBMC series – open, inclusive and trusted201717:112

https://doi.org/10.1186/s12872-017-0542-1

Received: 26 July 2016

Accepted: 28 April 2017

Published: 8 May 2017

Abstract

Background

Although disordered sleep patterns predispose to hypertension (HTN), little is known on the effect of the latter on sleep patterns in sub-Saharan Africa. This study therefore sought to generate preliminary data on the likelihood (risk) of Obstructive sleep apnea (OSA) in hypertensive patients, with the aid of sleep questionnaires.

Methods

This case–control study, age-and-sex-matched HTN patients with normotensive participants, and compared sleep patterns in either group determined with the aid of the Berlin Questionnaire (BQ) and Epworth Sleepiness Scale (ESS).

Results

Overall, 50 HTN and 54 age- and sex-matched normotensive participants were enrolled. The prevalence of snoring was higher in participants with hypertension compared to normotensives (58.0% versus 44.0% respectively), though not significantly, (p = 0.167). However, the hypertensive cases (aged on average 54.78 ± 8.79 years and with mean duration since diagnosis of 4.46 ± 4.36 years) had a significantly higher likelihood of Obstructive Sleep Apnea (OSA) than the controls (aOR = 5.03; 95% CI, 1.90–13.33, p = 0.001) and but no significant resulting daytime sleepiness (p = 0.421). There was no clear trend observed between both the risk of OSA and daytime sleepiness and HTN severity. Although not significant, participants with controlled hypertension had lower rates of risk of OSA compared to those with uncontrolled HTN (50.0% versus 63.2%, p = 0.718).

Conclusions

Preliminary findings of this study (the first of its kind in Cameroon) suggests that hypertension is positively associated with likelihood of OSA in Cameroon. Further studies are required to investigate this further and the role of sleep questionnaires in our setting, cheap and easy to use tools which can be used to identify early, patients with hypertension in need for further sleep investigations. This will contribute to improving their quality of life and adherence to anti-hypertension treatment.

Keywords

SleepSleep questionnairesObstructive sleep apneahypertensionCameroon

Background

Hypertension (HTN) is a growing worldwide [1] and national public health challenge for which several health surveys in developed and developing countries have revealed a high prevalence, a large percentage of them poorly controlled [24]. The disease occurs as a result of an interaction between environmental, genetic, social and lifestyle factors [5, 6], requiring multifactorial and multidisciplinary management approach for favorable outcomes.

Sleep plays an important role in the regulation of body processes and as such contributes significantly to the quality of life in humans [7]. Though known to be a restorative and refreshing process, over the past 50 years habitual sleep duration has decreased by 1.5 to 2 h/day, due to the evolving lifestyle and standards of living [8]. Sleep is characterized amongst other events by complex activity of the cardiovascular autonomic mechanisms and consequent changes in arterial pressure and heart rate [8]. Poor sleep has been recognized as independent risk factor of hypertension [9, 10] as it if often characterized by recurrent episodes of intermittent hypoxia. There is growing evidence that obstructive sleep apnea (OSA) a form of Sleep Disordered Breathing (SDB) is common among patients with hypertension, ranging from 37% [11] to 56% [12] as well as evidence that managing sleep disordered breathing improves blood pressure (BP) values and response to hypertensive treatment [13].

In Cameroon, sleep studies are few [14], and to our knowledge, no study so far has been carried out to assess sleep in hypertensive participants. It was hence essential to conduct assessments of sleep patterns of hypertensive patients in Cameroon with the aid of clinician-friendly, readily-available, less costly and easy-to-use sleep questionnaires, in order to generate preliminary data on the likelihood (risk) of obstructive sleep patterns (and consequent daytime sleepiness) in patients with hypertension compared to normotensive participants from which further exploration, management and awareness-raising initiatives can be conducted.

Methods

Study design

A case–control study carried in 50 consenting hypertensive participants age- and sex-matched with 54 normotensive participants.

Study setting and ethical considerations

The study was carried out in Yaoundé, the cosmopolitan capital city of Cameroon, specifically at the out-patient unit of the cardiology and neurology departments of the Yaoundé Central Hospital, a government run tertiary health facility which serves as referral centre for Yaoundé and its environs. In addition, the Neurology Department of this hospital has the lone sleep laboratory in the country that supports this kind of study.

Ethical approval was obtained from the institutional review board of the Faculty of Medicine and Biomedical Sciences (FMBS) of the University of Yaoundé 1, and administrative clearance from the directorate of the Yaoundé Central Hospital. Study participants provided informed consent and information they provided and patient files were coded and confidentially handled.

Study participants

Cases (hypertensive persons) included in the study were participants aged ≥ 18 years followed-up at the outpatient unit of the YCH, with mean blood pressure (BP) ≥140/90 mmHg or an optimal BP control, and who were on at least one anti-hypertensive drug. Individuals with abnormal sleep-wake cycles due to night-shift work, medication, history of tracheotomy, current home oxygen therapy (Continuous Positive Airway Pressure) treatment, as well as hypertensives patients with evidence of secondary hypertension, patients with history of target organ damage such as stroke, renal failure or myocardial infarction (obtained either during clerking or information gotten from patient files) and pregnant women were excluded.

For each case, a consenting normotensive participant (mean systolic blood pressure, SBP ≤ 140 mmHg and mean diastolic blood pressure, DBP ≤ 90 mmHg), of same age and sex, was enrolled from the community as control. A total of 113 participants were enrolled but at the time of analyses, 9 participants (5 participants with co-morbidity and 4 with incomplete data) were excluded giving a total of 104 participants (50 hypertensive and 54 normotensive participants).

Study instruments

Socio-demographic and clinical data of study participants were collected through interviews (in French and English, the languages commonly spoken by Cameroon’s numerous ethnic groups) with the aid of a pretested structured questionnaire. Data collected included age, sex, occupation, marital status, region of origin, address, history of diagnosis of hypertension, frequency of follow up, treatment strategy, number of current anti-hypertensive drugs, duration of treatment, cigarette smoking and alcohol status (for cases). All study participants underwent a complete physical examination with particular attention on neurological, cardiovascular and respiratory examination and anthropometric measurements.

The risk of obstructive sleep apnea was evaluated with the aid of the Berlin Questionnaire [15] and daytime sleepiness with the aid of the Epworth Sleepiness Scale [16].

Sleep quality (risk of OSA and Daytime sleepiness) was assessed and interpreted with the following scales as follows:
  • Scoring for OSA with the Berlin Questionnaire (BQ)
    • If ≥ 2 positive categories: participant considered High Risk of OSA

    • If ≤ 1 positive category: participant considered Low Risk of OSA

  • Scoring for daytime sleepiness with Epworth Sleepiness Scale (ESS)

The Epworth Sleepiness Scale is an 8-item questionnaire. Each question is graded from 0 to 3, depending on the likelihood to fall asleep during the day.
  1. 0-

    No chance of falling asleep,

     
  2. 1-

    Slight chance to fall asleep,

     
  3. 2-

    Moderate chances to fall asleep and

     
  4. 3-

    High chance to fall asleep.

     
The grading of the total ESS score as recommended by Rosenthal LD and Diana DC [17] was as follow:
  • 1–7 = Good; getting restful sleep.

  • 8–14 = Sleep debt.

  • 15 or higher = Excessive daytime somnolence

Definition of study variables

Exposure/independent variables:
  • Blood Pressure status: Classified as hypertensive or normotensive based on the average BP measurements as well as past history of hypertension controlled or not with appropriate management.

  • Classification of hypertension: Grouping into 4 stages according to the Joint National Committee (JNC) 8 staging algorithm [9] of blood pressure values obtained during clinical examination
    • Normal: Systolic BP < 120 mmHg and Diastolic BP < 80 mmHg

    • Pre-hypertension: Systolic BP = 120–139 mmHg or Diastolic BP = 80–89 mmHg

    • Stage 1 hypertension: Systolic BP = 140–159 mmHg or Diastolic BP = 90–99 mmHg

    • Stage 2 hypertension: Systolic BP ≥ 160 mmHg or Diastolic BP ≥ 100 mmHg

  • Treatment strategy: Classified as either lifestyle modifications only, pharmacologic or both. Year of diagnosis and disease duration: Year of diagnosis reported by the patient (confirmed by diagnosis report) after which disease duration was determined after comparing with study date. The latter were expressed in years and months respectively then categorized ordinally as shown on Table 3.

  • Number of routine visits to physician per year: As reported by study participants and confirmed by patient records. Assessed as continuous data and then ordinally categorized as shown on Table 2.

  • Number of anti-hypertensive drugs taken and compliance to treatment during the previous month was assessed in numerical order. Hypertensive participants were considered compliant if they reported not having missed taking prescribed anti-hypertensive medications not more than 7 times in a month.

  • Signs and symptoms of anxiety and depression: Determined using the 14 items Hospital anxiety and depression scale, which scores each item 0–3. A score of ≥11 is considered a case of depression.

Outcome/dependent variables:
  • Daytime sleepiness: Ordinally categorized with respect to ESS score: score of 1–7 (restful sleep and no daytime sleepiness), score 8–14 (sleep debt), score ≥ 15 (excessive daytime somnolence).

  • Risk of OSA: participants were considered as having a “high risk of OSA” if ≥2 categories were positive and “low risk of OSA” if ≤1category was positive.

Study covariantes

Age: Reported by study participants and grouped into 3 age groups: 25–49, 50–59, and ≥ 60 years.

Sex: Male/female dichotomous scale.

Marital status: Single, married, divorced or widowed.

Employment status: Participants were grouped into two categories: employed or unemployed.

Data analyses

Data collected was entered into an excel sheet and uploaded for analyses unto version 20 of the Statistical Package for Social Sciences (SPSS 20). Continuous data are presented as means ± SD as well as ordinate categories, and non-continuous data as proportions (%). Strengths of associations between categorical variables are presented as odds ratios and the differences between proportions determined with the aid of chi-squared tests (X 2). Differences between means of continuous variables when compared between groups were done with the aid of t-tests. Binary logistic regression permitted adjustments for potential confounders. All test statistics are two-sided and considered statistically significant at p < 0.05.

Results

Socio-demographic characteristics of the study population

A total of 104 participants were enrolled (50 hypertensive and 54 age- and sex- matched normotensive). The age of the participants ranged from 27 to 74 years with a mean age of 55.02 years (SD 8.69) and a sex ratio of 1.6 women for every 1 male (Table 1). No significant differences were noted between the cases and controls with regards to sociodemographic variables (Table 1).
Table 1

Socio-demographic characteristics of the study population

 

Hypertension status

p-value

Entire study sample

Normotensives

Participants with hypertension

N

%

n

%

N

%

Variable

54

51.9

50

48.1

104

100%

Sex

 Male

21

38.9

19

38.0

0.926

40

38.5

 Female

33

61.1

31

62.0

64

61.5

Age (years)

 Mean ± SD

55.24 ± 8.68

54.78 ± 8.79

0.789

55.02 ± 8.69

 25–49

10

18.5

10

20.0

0.974

20

19.2

 50–59

28

51.9

26

52.0

54

51.9

  ≥ 60

16

29.6

14

28.0

30

28.8

Employment status

 Employed

27

50.0

20

40.0

0.306

47

45.2

 Unemployed

27

50.0

30

60.0

57

54.8

Marital status

 Single

45

86.5

37

77.1

0.238

82

82.0

 Married

7

13.5

9

18.8

16

16.0

 Widow (ed)

0

0.0

2

4.2

2

2.0

Smoking

 Yes

0

0.0

0

0.0

 

0

0.0

 No

54

100.0

50

0.0

104

100.0

Alcohol consumption

 Yes

4

7.4

3

6.0

0.775

7

6.7

 No

50

92.6

47

94.0

97

93.3

On sleep medication

 No

54

100.0

50

100.0

 

104

100.0

Anthropometric and physical examination findings of participants

Cases (patients with hypertension) had a significantly higher BMI, waist circumference as well as systolic and diastolic blood pressures, compared to their normotensive counterparts (Table 2).
Table 2

Anthropometric and physical examination findings of participants

Variable

Hypertension status

p-value

Entire study sample

Normotensives

Participants with hypertension

N

%

N

%

 

n

%

BMI (kg/m2)

 Mean ± SD

28.74 ± 4.25

31.35 ± 5.86

0.011

29.99 ± 5.23

  Normal BMI (18.5–25.00)

12

22.2

6

12.0

0.039

18

17.3

  Overweight (25.01–29.99)

26

48.1

17

34.0

 

43

41.3

  Obese (≥30.00)

16

29.6

27

54.0

 

43

41.3

Neck circumference (cm)

 Mean ± SD

35.92 ± 3.96

37.22 ± 4.20

0.106

36.54 ± 4.11

  Normal

14

23.1

10

20.0

0.474

24

23.1

  Neck obesity

40

74.1

40

80.0

 

80

76.9

Waist circumference (cm)

 Mean ± SD

91.67 ± 10.11

98.32 ± 10.98

0.002

94.87 ± 11.00

  Normal

36

66.7

19

38.0

0.003

55

52.9

  Abdominal obesity

18

33.3

31

62.0

 

49

47.1

Pulse (/min)

 Mean ± SD

71.46 ± 10.34

73.24 ± 14.43

0.464

72.32 ± 12.28

Respiratory rate (cycles/min)

 Mean ± SD

17.65 ± 1.54

19.10 ± 7.25

0.154

18.35 ± 5.17

Blood pressure (mm/hg)

 Systolic (Mean ± SD)

129.41 ± 7.68

153.08 ± 22.90

<0.001

140.79 ± 20.52

 Systolic BP raised?

  Yes

1

1.9

36

72.0

<0.001

37

35.6

  No

53

98.1

14

28.0

 

67

64.4

 Diastolic (Mean ± SD)

     

72.32 ± 12.28

 

 Diastolic BP raised?

77.76 ± 8.98

90.46 ± 12.40

<0.001

  

  Yes

3

5.6

34

68.0

<0.001

37

35.6

  No

51

94.4

16

32.0

 

67

64.4

Clinical exam of other systems

 Normal

50

100.0

54

100.0

 

104

100.0

Conversely no significant differences were found between the two groups with regards to neck circumference, pulse rates and other physical examination findings (Table 2).

Profile of hypertensive participants

Hypertensive cases were aged 54.78 ± 8.79 years on average and most had been diagnosed less than 5 years ago (mean duration since diagnosis of 4.46 ± 4.36 years); (Table 3). None of the hypertensive patients were on non-pharmacological (life-style changes) treatment only, compared to 20% who were on pharmacological treatment only and 80% on both. Almost all (96.0%) self-reported being compliant and just 24% had their blood pressure controlled at the time of the study (Table 3).
Table 3

Profile of hypertensive participants

Variable

n

%

50

48.1

Number of years since diagnosis

 Mean ± SD

4.46 ± 4.36

  1–2

28

56.0

  3–5

9

18.0

  > 5

13

26.0

Current treatment strategy

  Non-pharmacological (lifestyle changes only)

0

0.0

  Pharmacological only

10

20.0

  Both

40

80.0

JNC classification of Hypertension

 Normal

00.

00

 Pre-hypertension

15

30

 Stage 1

17

34

 Stage 2

18

36

Complaint to treatment (self-reported)

 No

2

4.0

 Yes

48

96.0

Frequency of follow-up visits yearly

 Mean ± SD

3.94 ± 0.59

  1–2 visits

2

4.1

  3 or more

47

95.9

Other medication on other than anti-HBP

 None

44

88.0

 Statins

4

8.0

 Warfarin

1

2.0

 Other

1

2.0

Sleep medication use?

 No

50

100.0

HBP control

 Controlled BP (<140/90 mmHg)

12

24.0

 Uncontrolled BP (>140/90 mmHg)

38

76.0

Assessment of sleep patterns

High “risk”/likelihood of OSA was more common in hypertensive compared to normotensive participants (60% versus 20.4%, p < 0.001; OR 5.85, 95% CI 2.46–14.08); (Table 4). On adjusting for BMI the odds ratio of risk of poor sleep quality still remained high in participants with hypertension compared to normotensives (AOR 5.03; 95% CI, 1.90–13.33, p = 0.001).
Table 4

Sleep quality assessment in hypertensives compared to normotensives

 

Hypertension status

p-value

Entire study sample

OR (95% CI)

Normotensives

Participants with hypertension

N

%

n

%

 

N

%

 

OSA assessment (BQ score)

Snoring

 Yes

24

44.4

29

58.0

0.167

53

51.0

 

 No

30

55.6

21

42.0

 

51

49.0

 

No or Low “risk” of OSA

43

79.6

20

40.0

<0.001

63

60.6

5.85

High “risk” of OSA

11

20.4

30

60.0

 

41

39.4

(2.46–14.08)

Daytime sleepiness assessment (ESS score)

 Mean ESS score

7.20 ± 3.32

7.58 ± 4.55

0.629

7.38 ± 2.36

    

 No sleep debt

42

77.8

42

84.0

0.421

84

80.8

 

 Sleep debt and daytime sleepiness

12

22.2

8

16.0

 

20

19.2

 

No significant differences were found with regards to risk of OSA and resultant daytime sleepiness between hypertensive patients with controlled hypertension and those without as shown on the table below. On the other hand, resultant daytime sleepiness was non-significantly different between the two groups.

Discussion

This study sought to conduct a preliminary assessment of the likelihood (risk) of obstructive sleep apnea (OSA) and resultant daytime sleepiness in hypertensive individuals compared to normotensive participants (through an age- and sex- matched case–control study design) in the cosmopolitan city of Yaoundé, Cameroon in order to contribute to fill knowledge gaps in sub-Saharan Africa on subtle consequences of hypertension such as sleep quality which affect patient quality of life and compliance to treatment.

Our findings reported a higher likelihood (“risk”) of OSA (60% versus 20.4%, p < 0.001; OR 5.85, 95% CI 2.46–14.08; Table 4) in hypertensive compared to normotensive persons with a five-fold odds ratio even after adjusting for BMI (AOR 5.03; 95% CI, 1.90–13.33, p = 0.001). These findings are similar to what was reported in another study [18]. The suggested mechanism to explain the link between OSA and hypertension (HTN) is fluid-shift which involves nocturnal rostral fluid shift from the legs [19] leading to reduced mean upper airway cross-sectional area. Intermittent hypoxia coupled to the reduced upper airway, triggers the chemo-reflex receptors which in turn stimulates the sympathetic nervous system leading to vasoconstriction and resultant increase in BP levels contrary to expected reduction in BP levels (termed nocturnal dipping). Patients with hypertension studies have shown, are more prone to increased rostral fluid shift results in airway narrowing (which may explain why OSA is more common in patients with hypertension) which further pushes up BP worsening the hypertension [19, 20]. Further lends support to the fact that that hypertension can contribute to worsening hypertension through the OSA pathway.

Another incriminated mechanism in the pathophysiological relationship between HTN and OSA involves Aldosterone excess [2123], a hormone which assists in the regulation of circulating blood volumes and potassium concentration via a feedback loop within the adrenal cortex. In an observational study of consecutive participants with resistant HTN, participants were evaluated for primary hyperaldosteronism using plasma rennin activity <1.0 ng/mL/h and 24 h urinary aldosterone excretion >12 μg during high urinary sodium excretion (>200 mEq/24 h), and risk of sleep apnea with the aid of the Berlin Questionnaire [21]. Patients at high risk for OSA were almost two times more likely to have primary hyperaldosteronism (36% versus 19%, p < 0.05) with low plasma renin activity (1.2 ± 1.8 ng/mL/h versus 1.9 ± 4.1 ng/mL/h) and significantly greater 24 h urinary aldosterone excretion (13.6 ± 9.6 μg versus 9.8 ± 7.6 μg, p < 0.05) compared to participants at low risk of OSA, suggesting an association between primary hyperaldosteronism and OSA [21]. In another study by the same group, increased plasma aldosterone concentration and OSA were noted in patients with resistant HTN but not in control participants, suggesting that aldosterone excess may contribute to OSA severity [23]. These authors subsequently showed that OSA prevalence was significantly higher in participants with hyperaldosteronism compared with hypertensive patients with normal aldosterone levels (84% versus 77%). These findings suggest hyperaldosteronism may be a key factor in linking resistant HTN with OSA. These studies are, however, all observational and causality cannot be directly established.

Another proposed mechanism is the involvement of the structure and function of large arteries as well as ventricular remodeling. Hypertension is tightly linked to arterial stiffness (evaluated by pulse wave velocity) [12, 2426]. In hypertensive patients, structural, mechanical or functional remodeling (geometric alterations in the vessel wall without a change in vessel volume) due to apoptosis, low-grade inflammation and vascular fibrosis reduce small arteries and arterioles lumen diameter (determinants of vessel elasticity). These lead to decreased vascular compliance (due vascular wall structural changes) and increased peripheral resistance and impaired endothelium-dependent vasodilation (mediated in part by nitric oxide, a potent vasoactive substance produced by vascular endothelium), common in hypertensive patients [26, 27]. Vascular endothelial dysfunction (arterial stiffness) increases intra-arterial pressure (evaluated by Pulse Wave Velocity) resulting in the transudation of plasma into the interstitial space which in turn favors overnight rostral fluid shift, OSA and intermittent hypoxia. These trigger the Sympathetic Nervous System to further increase blood pressure, heart rate and arterial constriction. OSA independently is known to be associated with increased arterial stiffness which explains why the coexistence of OSA and treated hypertension is associated with additive effects on decreased vascular compliance.

Evidence suggests that OSA is associated with left ventricular (LV) hypertrophy [12, 24, 26]. Heart remodeling associated with OSA can be explained by several mechanisms. Acutely, recurrent hypoxia may have a direct effect on the aorta, promoting reduction in the amount of glycosaminoglycans and collagen as well as at the level of the heart [25]. Obstructive apneas is also characterized by negative intrathoracic pressure against an occluded upper airway, leading to LV transmural pressure increase (an important determinant of LV afterload). Cyclic increases in the BP due to apnea also contribute to increase LV afterload. These limit the aorta and proximal large vessels from serving as an elastic buffering chamber (the Windkessel function) which can store as much as 50% of the LV stroke volume during systole, leading to increased LV mass and LAD [25].

Hypertension on its part is not only associated with increased arterial stiffness but also with early signs of heart remodeling manifesting as increased Left Atrial Diameter (LAD), Interventricular Septal Wall Thickness (IVST), Left Ventricular Posterior Wall Thickness (LVPWT), LV mass index and percentage of LV hypertrophy as well as heart remodeling.

Anthropometric parameters such as BMI and neck circumference have equally been shown to affect sleep patterns in people including hypertensive patients. In our study, hypertensive participants were significantly more obese than normotensive participants. Despite adjusting for BMI with the aid of multivariate logistic regression analyses, hypertensive participants were 5 times more likely to have having a greater “risk” of OSA than normotensive participants [AOR: 5.03; 95% CI: 1.90–13.33, p = 0.001]. This was similar to what was reported in another study that studied the association between hypertension and risk of OSA assessed with the aid of the Berlin Questionnaire [28].

Though the prevalence of snoring (assessed with the aid of the Berlin Questionnaire was higher in participants with hypertension compared to normotensives (58.0% versus 44.0% respectively), the difference was not significant, p = 0.167); Table 4. This was inconsistent with the results of a similar study which revealed a significantly higher prevalence of snoring in participants with resistant hypertension [29]. This discrepancy could be explained by our relatively small sample size compared to the latter study.

This study showed controlled hypertensive participants (hypertensive patients on anti-hypertensive treatment with BP <140/90 mmHg) had a relatively lower risk of OSA (50% versus 63.2%) than those with uncontrolled hypertension (Table 5), which difference was however not significant (p = 0.718). Our relatively small sample size may explain the absence of a significant difference for adequate BP control may lead to a relatively better sleep quality via a reduction in nocturnal rostral fluid shift (proportional to the amount of fluid displaced from the legs) which as explained above has been postulated in participants with hypertension with resultant reduction of mean upper airway cross-sectional area. This is supported by literature which suggests upper airway reduction literature is significantly more pronounced in the patients with uncontrolled hypertensive compared with controlled hypertensive participants [20, 30]. Further studies are required to further investigate this relationship.
Table 5

Sleep parameters with respect to level of BP Control

Variable

Hypertension Control

p-value

Entire Hypertensive Sample

Controlled Hypertension

Uncontrolled Hypertension

N

%

N

%

 

N

%

12

24.0

38

76.0

 

50

100.0

OSA assessment (BQ score)

Snoring

 Yes

6

50.0

23

60.5

0.520

29

58.0

 No

6

50.0

15

39.5

 

21

42.0

Low “risk” of OSA

6

50.0

14

36.8

0.417

20

40.0

High “risk” of OSA

6

50.0

24

63.2

 

30

60.0

Daytime sleepiness assessment (ESS score)

 Mean ESS score

8.00 ± 4.79

7.45 ± 4.54

0.718

7.58 ± 4.55

   

 No sleep debt

10

83.3

32

84.2

1.00

42

84.0

 Sleep debt and daytime sleepiness

2

16.7

6

15.8

 

8

16.0

We also did not observe a trend increasing risk of OSA with respect to the BP severity (assessed as per JNC classification of hypertension severity). This absence of a trend may be due to our study sample size. Larger scale studies are needed to further investigate the relationship between OSA and hypertension severity.

Resultant daytime sleepiness (measured by Epworth Sleepiness Score) was not significantly different between cases and normotensive participants. This finding is similar to that reported by other studies [27, 2931]. The absence of a difference may be as a result of repeated sympathetic nervous system firing during the day which maintains an alert and awake state.

All the hypertensive participants in our sample were on anti-hypertensive drugs (a mean of 2 drugs per person). Amongst these participants, 12 (24%) had well controlled BP (<140/90 mmHg) as recommended by the European Society of Hypertension (ESH) and the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure [9, 10] as opposed to 38 (76%) who were not controlled (>140/90 mmHg). This proportion of controlled hypertension though higher than that of previous blood pressure control studies in Cameroon [32, 33], is lower than that obtained by Katte and collaborators in a similar setting and on a larger sample [34] as well as rates reported in the US as part of the National Health and Nutrition Examination Survey (NHANES) [8].

The tendency for persons with hypertension to seek treatment is the result of the efforts of several screening and health education campaigns. Significantly greater mean BMI, mean neck circumference and mean waist circumference among the uncontrolled HBP cases compared to those with controlled BP could possibly link account for the poor BP control.

This study has some limitations that should be considered in designing future sleep studies. First, its cross-sectional study design gives only a snapshot and its results may be different or more conclusive if a prospective design had been chosen. The relatively small sample size might explain the unintentional absence of smokers in the study sample, which affects the study’s generalizability to the general Cameroonian population where 1 in every 9 persons smokes [34]. This weakness is however a strength and suggests that the observed high likelihood of obstructive sleep apnea in patients with hypertension compared to controls, is likely due to the pathological changes explained above, observed in hypertension and not (directly) smoking, a known risk factor for sleep apnea. Sleep questionnaires though user-friendly, easy to use and cheaper, can be subjective tools in assessing sleep compared to other methods like polysomnography and actigraphy. This was minimized by coaching participants on filling the sleep questionnaires. Studies are needed to determine the sensitivity, specificity and validity of these sleep questionnaires in our settings, as quick and reliable tools to detect disordered sleep, by comparing them with gold standards. Finally this pilot study involved a small hospital-based sample. The weakness of hospital data can best be dealt with by conducting large and community-based studies which time and resources could not permit. However, the study’s hospital-based participants were age-and-sex matched with community-based controls to improve quality.

Conclusions

This study provides preliminary data on sleep disorders in a sample of hypertensive participants in a sub-Saharan situation. The higher prevalence of the risk of OSA in hypertensive compared to normotensive participants is worth noting. Further larger scale and prospective studies however need to be carried out using detailed investigations (actigraphy, polysomnography) and biological markers to shed more light on the pattern of sleep in participants with hypertension in our setting as opposed normotensives and how it impacts blood pressure values. More emphasis on subtle consequences of hypertension like sleep perturbation should be given during follow-up of patients with hypertension so as to limit its impact on treatment adherence, disease progression and quality of life. Sleep questionnaires validated for use in our setting against gold standards could be used in the clinical settings as simple and quick tools to determine those at risk and in need for further investigation.

Abbreviations

BP: 

Blood pressure

BQ: 

Berlin Questionnaire

DBP: 

Diastolic blood pressure

ESS: 

Epworth Sleepiness Scale

HBP: 

High blood pressure

HTN: 

Hypertension

JNC: 

Joint National Committee

LV: 

Left ventricle

OSA: 

Obstructive sleep apnea

SBP: 

Systolic blood pressure

SDB: 

Sleep Disordered Breathing

Declarations

Acknowledgments

Our gratitude to staff of the out-patients, neurology and cardiology departments of the study center for their contributions to data collection. We equally thank the article’s peer reviewers, as well as panel of professors of the Faculty of Medicine and Biomedical Sciences of the University of Yaoundé 1 who reviewed this work as part of an end-of-MD thesis exercise.

Funding

Not applicable.

Availability of data and materials

Data obtained from participants are available in the form of Excel sheets and can be shared on request.

Authors’ contributions

AKN and SK conceived the study; AKN, SK, MKM and ENM designed the study and collected study data. MKM and ENM did the data analyses. All authors reviewed the article drafts and approved the submitted version.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not Applicable.

Ethics approval and consent to participate

Ethical approval was obtained from the institutional review board of the Faculty of Medicine and Biomedical Sciences (FMBS) of the University of Yaoundé 1, and administrative clearance from the directorate of the Yaoundé Central Hospital. Study participants provided informed consent, and information they provided including patient files, were coded and confidentially handled.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1
(2)

References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.View ArticlePubMedGoogle Scholar
  2. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5):963–75.View ArticleGoogle Scholar
  3. Members WG, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics—2010 update: a report from the American heart association. Circulation. 2010;121(7):e46–e215.View ArticleGoogle Scholar
  4. Nwankwo T, Yoon S, Burt V, Gu Q. Hypertension among adults in the United States: national health and nutrition examination survey, 2011–2012. Hyattsville: NCHS Data Brief, no 133. National Center for Health Statistics; 2013.Google Scholar
  5. Fung MM, Zhang K, Zhang L, Rao F, O’Connor DT. Contemporary approaches to genetic influences on hypertension. Curr Opin Nephrol Hypertens. 2011;20(1):23–30.View ArticlePubMedGoogle Scholar
  6. Kuneš J, Zicha J. The interaction of genetic and environmental factors in the etiology of hypertension. Physiol Res. 2009;58:S33.PubMedGoogle Scholar
  7. Schwartz JR, Roth T. Neurophysiology of Sleep and Wakefulness: Basic Science and Clinical Implications. Curr Neuropharmacol. 2008;6(4):367–78.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Bansil P, Kuklina EV, Merritt RK, Yoon PW. Associations between sleep disorders, sleep duration, quality of sleep, and hypertension: results from the national health and nutrition examination survey, 2005 to 2008. J Clin Hypertens (Greenwich, Conn). 2011;13(10):739–43.View ArticleGoogle Scholar
  9. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.View ArticlePubMedGoogle Scholar
  10. Mancia, G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force Members (2013) 2013 ESH/ESC. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-357.Google Scholar
  11. Sjostrom C, Lindberg E, Elmasry A, Hagg A, Svardsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax. 2002;57(7):602–7.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol. 2010;105(8):1135–9.View ArticlePubMedGoogle Scholar
  13. Martínez-García M, Capote F, Campos-Rodríguez F, et al. Effect of cpap on blood pressure in patients with obstructive sleep apnea and resistant hypertension: The hiparco randomized clinical trial. JAMA. 2013;310(22):2407–15.View ArticlePubMedGoogle Scholar
  14. Njoh AA, Mbong EN, Mbi VO, Mengnjo MK, Nfor LN, Ngarka L, Chokote SE, Fonsah JY, Kingue S, Ntone FE, Njamnshi AK. Likelihood of obstructive sleep apnea in people living with HIV in Cameroon – preliminary findings. Sleep Sci Pract. 2017;1:4.View ArticleGoogle Scholar
  15. Grover M, Mookadam M, Armas D, Bozarth C, Castleberry T, Gannon M, et al. Identifying patients at risk for obstructive sleep apnea in a primary care practice. J Am Board Fam Med. 2011;24(2):152–60.View ArticlePubMedGoogle Scholar
  16. Pahwa P, Karunanayake CP, Hagel L, Gjevre JA, Rennie D, Lawson J, et al. Prevalence of high Epworth sleepiness scale scores in a rural population. Can Respir J. 2012;19(2):e10–4.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Rosenthal LD, Diana DC. The Epworth sleepiness scale in the identification of obstructive sleep apnea. J Nerv Ment Dis. 2008;196:429–31.View ArticlePubMedGoogle Scholar
  18. Lombardi C, Carabalona R, Lonati L, Salerno S, Mattaliano P, Colamartino E, et al. Hypertension and obstructive sleep apnea: is the Berlin questionnaire a valid screening tool?: Pp.32.273. J Hypertens. 2010;28:e531.Google Scholar
  19. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD. Nocturnal rostral fluid shift a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121:1598–605.View ArticlePubMedGoogle Scholar
  20. Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Su MC, Lam J, et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med. 2009;179:241–6.View ArticlePubMedGoogle Scholar
  21. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among participants with resistant hypertension and symptoms of sleep apnea. Chest. 2004;125(1):112–7.View ArticlePubMedGoogle Scholar
  22. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in participants with resistant hypertension. Chest. 2007;131(2):453–9.View ArticlePubMedGoogle Scholar
  23. Pimenta E, Stowasser M, Gordon RD, Harding SM, Batlouni M, Zhang B, et al. Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. Chest. 2013;143(4):978–83.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Tsioufis C, Thomopoulos K, Dimitriadis K, Amfilochiou A, Tousoulis D, Alchanatis M, et al. The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive participants. J Hypertens. 2007;25(1):141–6.View ArticlePubMedGoogle Scholar
  25. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. OBstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131(5):1379–86.View ArticlePubMedGoogle Scholar
  26. Wolk R, Shamsuzzaman ASM, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension. 2003;42(6):1067–74.View ArticlePubMedGoogle Scholar
  27. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison’s Prinicples of Internal Medicine 18E Vol 2 EB. New York: McGraw Hill Professional; 2012.Google Scholar
  28. Gus M, Gonçalves SC, Martinez D, de Abreu Silva EO, Moreira LB, Fuchs SC, et al. Risk for obstructive sleep apnea by Berlin questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case–control study. Am J Hypertens. 2008;21(7):832–5.View ArticlePubMedGoogle Scholar
  29. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LKG, Amaro ACS, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811–7.View ArticlePubMedGoogle Scholar
  30. Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension. 2010;56(6):1077–82.View ArticlePubMedGoogle Scholar
  31. Gus M, Silva DN, Fernandes J, Cunha CP, Sant’Anna GD. Epworth’s sleepiness scale in outpatients with different values of arterial blood pressure. Arq Bras Cardiol. 2002;78:21–4.Google Scholar
  32. Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC. Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon burden of diabetes baseline survey. J Hum Hypertens. 2005;20(1):91–2.View ArticleGoogle Scholar
  33. Kengne AP, Awah PK, Fezeu L, Mbanya JC. The burden of high blood pressure and related risk factors in urban sub-Saharan Africa: evidences from Douala in Cameroon. Afr Health Sci. 2007;7(1):38–44.PubMedPubMed CentralGoogle Scholar
  34. Katte JC, Dzudie A, Sobngwi E, Mbong EN, Fetse GT, Kouam CK, et al. Coincidence of diabetes mellitus and hypertension in a semi-urban Cameroonian population: a cross-sectional study. BMC Public Health. 2014;14:696.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement